ArticleLeukemia2018

Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myeloma.

Xiaohui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.